Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The treatment was ineffective in humans.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Exosome-based therapy successfully restored hair in a 14-year-old with difficult-to-treat alopecia areata.

AP-1 controls tumor cell type by affecting key signaling pathways.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Polygonum multiflorum extract helps grow hair by activating certain hair growth signals in mice.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

The study found that a specific area of the hair follicle helps start hair growth by reducing the blocking effects on certain cells and controlling growth signals.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

Gray hair can potentially be reversed, leading to new treatments.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Cancer treatments often cause skin, nail, and hair problems.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Scientists can control how skin stem cells divide by using different treatments.

Immune cells are crucial for hair growth and preventing hair loss.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hedgehog signaling can create new hair follicles in adult skin but may increase cancer risk.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

Some drugs can cause permanent hair loss, though it's rare.